HALO logo
halo search icon
Unicycive Therapeutics, Inc.

US$7.74

Price Change Indicator
0.01 (0.129%)
Unicycive Therapeutics, Inc.
UNCY · NAS

Unicycive Therapeutics, Inc.

Start Trading UNCY for Free

US$7.74

Price Arrow0.01 (0.129%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Price MomentumRecent Earnings downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Unicycive Therapeutics, Inc. Overview

UNCY Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Strong

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About UNCY

icon

Website

Unicycive Therapeutics, Inc.

icon

Telephone

1.650.351.4495

icon

Address

Suite 210, 4300 El Camino Real, Los Altos, CA 94022

Description

Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

UNCY Price Chart

Key Stats

Market Cap

US$206.39M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.71 - 11

Trade Value (12mth)

US$836,547.00

1 week

-6.42%

1 month

7.21%

YTD

33.28%

1 year

35.61%

All time high

87.30

Key Fundamentals

EPS 3 yr Growth

-86.10%

EBITDA Margin

0.00%

Operating Cashflow

-$31m

Free Cash Flow Return

-165.90%

ROIC

-140.70%

Interest Coverage

-407.70

Quick Ratio

2.60

Other Data

Shares Outstanding (Fully Diluted)

24m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

UNCY Announcements

Latest Announcements

DateAnnouncements
12 May 26
12 May 26
12 May 26
12 May 26
12 May 26

UNCY Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-12.8-5.65-1.67locklocklock
EPS (Fully Diluted)
 $locklocklocklock-12.8-5.65-1.67locklocklock
Growth
 %locklocklocklock-6.755.970.4locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Unicycive Therapeutics, Inc. (UNCY:NAS)?
Halo FAQ
The current share price of Unicycive Therapeutics, Inc. (UNCY:NAS) is USD$7.74.
What is the 52-week high share price for Unicycive Therapeutics, Inc. (UNCY:NAS)?
Halo FAQ
The 52-week high share price for Unicycive Therapeutics, Inc. (UNCY:NAS) is USD$11.00.
What is the 52-week low share price for Unicycive Therapeutics, Inc. (UNCY:NAS)?
Halo FAQ
The 52-week low share price for Unicycive Therapeutics, Inc. (UNCY:NAS) is USD$3.71.
What is the dividend yield for Unicycive Therapeutics, Inc. (UNCY:NAS)?
Halo FAQ
Unicycive Therapeutics, Inc. (UNCY:NAS) does not pay a dividend.
What was Unicycive Therapeutics, Inc. (UNCY:NAS) last dividend payment?
Halo FAQ
Unicycive Therapeutics, Inc. (UNCY:NAS) does not pay a dividend.
What is the franking level for Unicycive Therapeutics, Inc. (UNCY:NAS)?
Halo FAQ
Unicycive Therapeutics, Inc. (UNCY:NAS) has a franking level of 0.00%.
In which sector is Unicycive Therapeutics, Inc. (UNCY:NAS) classified?
Halo FAQ
Unicycive Therapeutics, Inc. (UNCY:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial